InnoCare Pharma Limited
HKEX:9969.HK
7.03 (HKD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||
| Net Income
| -644.206 | -893.727 | -20.121 | -464.263 | -2,150.351 | -554.023 | -341.734 |
| Depreciation & Amortization
| 92.621 | 68.403 | 32.482 | 11.451 | 9.066 | 5.388 | 3.718 |
| Deferred Income Tax
| 0 | 0 | 41.078 | 44.85 | 70.7 | 8.42 | 0.182 |
| Stock Based Compensation
| 65.103 | 129.477 | 126.444 | 215.621 | 65.804 | 65.215 | 10.395 |
| Change In Working Capital
| -243.886 | -75.1 | 119.525 | -56.545 | 21.234 | 47.225 | 3.073 |
| Accounts Receivables
| -194.529 | -82.653 | -45.153 | -0.115 | 0.007 | -0.044 | 0.002 |
| Inventory
| -42.461 | -52.116 | -8.04 | -1.878 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 82.653 | 45.153 | 0.115 | 0 | 0 | 0 |
| Other Working Capital
| -21.343 | -22.984 | 127.565 | -54.667 | 21.227 | -10.8 | 7.552 |
| Other Non Cash Items
| -103.301 | 205.393 | -132.35 | 76.367 | 1,903.794 | 410.098 | 275.01 |
| Operating Cash Flow
| -671.34 | -565.554 | 167.058 | -172.519 | -79.753 | -17.677 | -49.356 |
| Investing Activities: | |||||||
| Investments In Property Plant And Equipment
| -254.655 | -370.327 | -167.069 | -251.266 | -45.497 | -20.082 | -1.417 |
| Acquisitions Net
| 1.152 | -20 | -0.868 | 0.271 | -0.464 | -16.458 | -0.132 |
| Purchases Of Investments
| -4,129.314 | -1,824.37 | -4,248.94 | -1,106.139 | -1,153.206 | -1,114.914 | -143.43 |
| Sales Maturities Of Investments
| 5,043.869 | 413.372 | 2,691.035 | 250.457 | 1,175.707 | 324.47 | 171.033 |
| Other Investing Activites
| 5.85 | 74.971 | -4.123 | -0.271 | 70.928 | -61.125 | -0.881 |
| Investing Cash Flow
| 666.914 | -1,726.354 | -1,729.965 | -1,106.948 | 47.468 | -888.109 | 25.173 |
| Financing Activities: | |||||||
| Debt Repayment
| -31.3 | -21.775 | -14.916 | -9.024 | -50 | -56.508 | -20 |
| Common Stock Issued
| 9.947 | 2,923.23 | 2,527.459 | 2,355.855 | 9.342 | 0 | 0 |
| Common Stock Repurchased
| -6.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | -3.263 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 3.937 | 193.051 | 32.264 | -108.86 | 403.599 | 2,157.808 | 46.81 |
| Financing Cash Flow
| 1.308 | 3,094.506 | 2,544.807 | 2,237.971 | 362.941 | 2,101.3 | 26.81 |
| Other Information: | |||||||
| Effect Of Forex Changes On Cash
| 25.698 | 139.902 | -45.297 | -251.776 | 18.293 | 12.816 | 2.019 |
| Net Change In Cash
| 22.58 | 942.5 | 936.603 | 706.728 | 348.949 | 1,208.33 | 4.646 |
| Cash At End Of Period
| 4,202.564 | 4,179.984 | 3,237.484 | 2,300.881 | 1,594.153 | 1,245.204 | 36.874 |